In an interview with Dr. Phil, the Kennedy offered false information about vaccine oversight and revealed a lack of understanding of new drug approvals.

In an interview with Dr. Phil, the health secretary offered false information about vaccine oversight and revealed a lack of ...

Following massive layoffs and cuts at the FDA, Makary’s plan for the agency is yet to fully unfold. But he has hinted at what ...

As tariffs, HHS workforce cuts and the ouster of CBER Director Peter Marks threaten the “lifeblood” of the cell and gene ...

The FDA has discussed with vaccine-maker Novavax the need for an additional trial of its COVID-19 vaccine as a post-approval ...

As Marty Makary nears the end of his first month on the job, the FDA Commissioner sat down for two interviews, offering ...

The new FDA chief reiterated his commitment to speeding up drug approval processes and run the agency by “gold standard ...

Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...

A vow by the agency’s new commissioner, Marty Makary, to support innovation might ease fears stoked by Health and Human ...

US Food and Drug Administration Commissioner Dr. Marty Makary suggested in a new interview that autism is caused by a range ...

For a view on that, I'm joined now by Dr. Peter Marks. Dr. Marks was the top vaccine regulator at the Food and Drug Administration until last month when he was forced out after clashing with Kennedy.

Dr. Peter Marks, Former Director of the FDA's Center for Biologics Evaluation and Research, spoke with Margaret Brennan on ...